πŸ‡ΊπŸ‡Έ FDA
Patent

US 11957686

Compositions for delivery of reboxetine

granted A61KA61K31/5375A61K9/2013

Quick answer

US patent 11957686 (Compositions for delivery of reboxetine) held by AXSOME THERAPEUTICS, INC. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/5375, A61K9/2013, A61K9/2027, A61K9/2054